New Zealand markets closed

NVS Oct 2022 77.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.60000.0000 (0.00%)
At close: 12:04PM EDT
Full screen
Previous close1.6000
Open1.6000
Bid1.4500
Ask1.6000
Strike77.50
Expiry date2022-10-21
Day's range1.6000 - 1.6000
Contract rangeN/A
Volume114
Open interest118
  • Zacks

    Novartis (NVS) Announces Positive Data on Oncology Drug

    Novartis' (NVS) anti-PD-1 monoclonal antibody, tislelizumab, significantly extends median overall survival in first-line advanced esophageal cancer combined with chemotherapy.

  • Zacks

    The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J

    Sanofi, Merck, Novartis, Pfizer and J&J are part of Zacks top Analyst Blog.

  • Bloomberg

    Novartis Leaning Toward Spinoff of $25 Billion Generics Arm

    (Bloomberg) -- Novartis AG is leaning toward a spinoff of its generic-drug unit, as a challenging environment for leveraged buyouts makes a potential sale to private equity more difficult, people familiar with the matter said. Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysThe Wheels Have Come Off Electric VehiclesCrypto Meltdown Claims Rolex and Patek Philippe as VictimsStock Doomsayers Vindicated in Historic First Half: Markets WrapUkraine Latest: Kyiv La